Diclofenac versus fluorometholone after strabismus surgery in children

Hee Kyung Yang1, Sang Beom Han2, Jeong-Min Hwang1

  • 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Insights

Topical diclofenac effectively manages intraocular pressure after strabismus surgery, unlike fluorometholone, especially in children under seven. Diclofenac offers a safer alternative to steroid eye drops for pediatric patients.

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Strabismus surgery requires effective postoperative management to control inflammation and intraocular pressure (IOP).
  • Steroidal anti-inflammatory drugs are commonly used but can increase IOP.

Purpose of the Study:

  • To compare the efficacy of topical diclofenac sodium versus fluorometholone in managing IOP and conjunctival inflammation post-strabismus surgery.

Main Methods:

  • Retrospective analysis of 60 Korean children undergoing strabismus surgery for intermittent exotropia.
  • Patients received either topical diclofenac 0.1% or fluorometholone 0.1% for up to 4 weeks.
  • Evaluated IOP, discomfort, conjunctival inflammation, and injection at 1, 2, 3, and 4 weeks.

Main Results:

  • Fluorometholone group showed a significant IOP increase (p<0.001) compared to baseline; 23% experienced ≥10 mm Hg rise.
  • Diclofenac group demonstrated no significant IOP increase.
  • Higher risk of IOP elevation (≥10 mm Hg) with fluorometholone in children under 7.
  • No significant differences in discomfort, inflammation, or injection between groups.

Conclusions:

  • Topical diclofenac is a suitable steroid substitute for managing IOP after strabismus surgery.
  • Diclofenac is particularly recommended for young children under 7 years old due to the risks associated with fluorometholone.
Abstract